US2023329978A1PendingUtilityA1
Synthesis of antimicrobial silsesquioxane-silica hybrids
Assignee: KIMMERLING HOLDINGS GROUP LLCPriority: Aug 16, 2013Filed: May 8, 2023Published: Oct 19, 2023
Est. expiryAug 16, 2033(~7.1 yrs left)· nominal 20-yr term from priority
A61K 6/20C08G 77/442C01B 33/18C08K 3/36C07F 7/188C07F 7/21C01B 33/113C08G 83/001C07F 7/0838C08F 230/08C08G 77/20A01N 55/00C08G 77/26C08F 236/00A01N 25/10C09D 4/00C08F 230/085
74
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
One-pot synthetic methods are disclosed for synthesizing curable, antimicrobial silsesquioxane-silica hybrids by hydrolytically co-condensing a tetraalkoxysilane with two different trialkoxysilanes. Particles are also disclosed that are substantially spherical and have an ordered lamellar internal structure. In addition, polymers prepared from the curable, antimicrobial silsesquioxane-silica hybrids and co-monomers are disclosed.
Claims
exact text as granted — not AI-modified1 - 42 . (canceled)
43 . A plurality of particles, wherein each of said particles comprises:
a silsesquioxane-silica hybrid; wherein each of said particles has a substantially spherical morphology; wherein each of said particle has a substantially ordered lamellar internal structure; wherein each of said particles is mesoporous; and comprising a reacted residue of a trialkoxysilane of formula III:
wherein
R a is independently a functional group comprising at least one curing group selected from the group consisting of acrylate, methacrylate, (C 2 -C 8 )alkenyl, glycidyloxy, epoxy, sulfonate, carboxylate, ester, amino, acrylamide, methacrylamide, isocyanato, amino acid, nucleic acid, and mercapto(C 1 -C 6 )alkyl;
R b is independently
wherein:
R c is (C 1 -C 2 )alkyl;
R d is (C 1 -C 2 )alkyl or phenyl;
R e is (C 6 -C 22 )alkyl;
X − is an anion selected from the group consisting of chloride, bromide, fluoride, iodide, sulfonate, and acetate; and
each R Y is, independently, H, (C 1 -C 8 )alkyl, or trifluoro-substituted (C 1 -C 8 )alkyl, are substantially homogeneously distributed throughout each of said particle; and
a reacted residue of a tetraalkoxysilane of formula I:
wherein A 1 , A 2 , A 3 , and A 4 are each independently selected from the group consisting of H, C 1 -C 8 alkyl, and trifluoro-substituted (C 1 -C 8 )alkyl,
is in a molar ratio of from 1-32 with the trialkoxysilane of formula III, and
the reacted residues are substantially homogenously distributed throughout each of said particles.
44 . The particles of claim 43 , wherein A 1 , A 2 , A 3 , and A4 are each ethyl.
45 . The particles of claim 44 , wherein R c and R d are methyl, and R 3 is octadecyl.
46 . A method of preparing a silsesquioxane-silica hybrid particles, comprising:
hydrolytically co-condensing a tetraalkoxysilane of formula I:
with a trialkoxysilane of formula II:
or a trialkoxysilane of formula III:
wherein:
A 1 , A 2 , A 3 , and A 4 are each independently selected from the group consisting of H, C 1 -C 8 alkyl, and trifluoro-substituted (C 1 -C 8 )alkyl;
R a is independently a functional group comprising at least one curing group selected from the group consisting of acrylate, methacrylate, (C 2 -C 8 )alkenyl, glycidyloxy, epoxy, sulfonate, carboxylate, ester, amino, acrylamide, methacrylamide, isocyanato, amino acid, nucleic acid, and mercapto(C 1 -C 6 )alkyl;
R b is independently
wherein:
R c is (C 1 -C 2 )alkyl;
R d is (C 1 -C 2 )alkyl or phenyl;
R e is (C 6 -C 22 )alkyl;
X − is an anion selected from the group consisting of chloride, bromide, fluoride, iodide, sulfonate, and acetate; and
each R Y is, independently, H, (C 1 -C 8 )alkyl, or trifluoro-substituted (C 1 -C 8 )alkyl,
wherein:
each of said particles has a substantially spherical morphology;
each of said particle has a substantially ordered lamellar internal structure; and
each of said particles is mesoporous;
47 . The method of claim 46 , wherein A 1 , A 2 , A 3 , and A4 are each ethyl.
48 . The method of claim 47 , wherein R c and R d are methyl, and R 3 is octadecyl.
49 . The method of claim 46 , wherein R a is a functional group comprising a methacrylate.
50 . The method of claim 49 , wherein R a is methacryloxypropyl.
51 . The method of claim 50 , wherein said trialkoxysilane of formula II is 3-methacryloxypropyltrimethoxysilane (3-MPTS).
52 . A plurality of particles, prepared by the process of claim 46 .Join the waitlist — get patent alerts
Track US2023329978A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.